Marion Mc Court is EVP Commercial of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,931 shares of REGN, which is worth approximately $12.7 Million. The most recent transaction as insider was on May 01, 2024, when has been sold 250 shares (Common Stock) at a price of $889.41 per share, resulting in proceeds of $222,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.9K
3.72% 3M change
37.08% 12M change
Total Value Held $12.7 Million

Marion McCourt Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 01 2024
SELL
Open market or private sale
$222,352 $889.41 p/Share
250 Reduced 1.9%
12,931 Common Stock
Apr 01 2024
SELL
Open market or private sale
$241,182 $964.73 p/Share
250 Reduced 1.86%
13,181 Common Stock
Mar 01 2024
SELL
Open market or private sale
$346,365 $967.5 p/Share
358 Reduced 2.6%
13,431 Common Stock
Feb 05 2024
SELL
Open market or private sale
$934,710 $934.71 p/Share
1,000 Reduced 6.76%
13,789 Common Stock
Feb 01 2024
SELL
Open market or private sale
$258,151 $945.61 p/Share
273 Reduced 1.81%
14,789 Common Stock
Jan 02 2024
SELL
Open market or private sale
$239,451 $873.91 p/Share
274 Reduced 1.79%
15,062 Common Stock
Dec 12 2023
SELL
Payment of exercise price or tax liability
$4,373,504 $856.71 p/Share
5,105 Reduced 24.97%
15,336 Common Stock
Dec 11 2023
SELL
Payment of exercise price or tax liability
$314,845 $844.09 p/Share
373 Reduced 1.79%
20,441 Common Stock
Dec 11 2023
SELL
Open market or private sale
$226,378 $838.44 p/Share
270 Reduced 1.28%
20,814 Common Stock
Dec 08 2023
SELL
Payment of exercise price or tax liability
$718,909 $843.79 p/Share
852 Reduced 4.3%
18,951 Common Stock
Dec 08 2023
BUY
Grant, award, or other acquisition
-
2,133 Added 9.19%
21,084 Common Stock
Nov 01 2023
SELL
Open market or private sale
$783,910 $783.91 p/Share
1,000 Reduced 4.81%
19,803 Common Stock
Nov 01 2023
BUY
Exercise of conversion of derivative security
$381,400 $381.4 p/Share
1,000 Added 4.59%
20,803 Common Stock
Oct 02 2023
SELL
Open market or private sale
$858,426 $827.0 p/Share
1,038 Reduced 4.98%
19,803 Common Stock
Oct 02 2023
BUY
Exercise of conversion of derivative security
$386,613 $372.46 p/Share
1,038 Added 4.74%
20,841 Common Stock
Sep 01 2023
SELL
Open market or private sale
$208,637 $834.55 p/Share
250 Reduced 1.25%
19,803 Common Stock
Aug 01 2023
SELL
Open market or private sale
$186,165 $744.66 p/Share
250 Reduced 1.23%
20,053 Common Stock
Jul 03 2023
SELL
Open market or private sale
$177,522 $710.09 p/Share
250 Reduced 1.22%
20,303 Common Stock
Jun 01 2023
SELL
Open market or private sale
$184,000 $736.0 p/Share
250 Reduced 1.2%
20,553 Common Stock
Apr 03 2023
SELL
Open market or private sale
$900,680 $818.8 p/Share
1,100 Reduced 5.02%
20,803 Common Stock
Apr 03 2023
BUY
Exercise of conversion of derivative security
$409,706 $372.46 p/Share
1,100 Added 4.78%
21,903 Common Stock
Mar 01 2023
SELL
Open market or private sale
$835,879 $759.89 p/Share
1,100 Reduced 5.02%
20,803 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
$409,706 $372.46 p/Share
1,100 Added 4.78%
21,903 Common Stock
Feb 12 2023
SELL
Payment of exercise price or tax liability
$959,271 $751.78 p/Share
1,276 Reduced 5.78%
20,803 Common Stock
Feb 07 2023
SELL
Open market or private sale
$769,040 $769.04 p/Share
1,000 Reduced 4.33%
22,079 Common Stock
MM

Marion Mc Court

EVP Commercial
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN